Daily programme - 07 June 2026

• Welcome Message
  GeorgiosSflomos Chair EPFLSwitzerland
• Therapeutic OVERactivation of oncogenic signaling as a cancer treatment strategy
  MatheusHenriqueDias Speaker Princess Máxima CenterNetherlands
• Proffered Paper 1: Lipid-associated macrophages in amoeboid cancer cell dissemination
  EACR26-1833
  SamanthaLaurenGeorge Speaker Institute of Cancer ResearchUnited Kingdom
• Proffered Paper 2: Spatial/single-cell profiling of Tfh niches and CD8 exhaustion in glofitamab resistance
  EACR26-0682
  PaulMarcoux Speaker CRCT - INSERMFrance
• Raising from the ashes of treatment – understanding and targeting persister cells
  YaaraOren Speaker Tel Aviv UniversityIsrael

• Synthetic immunology approaches to target blood cancers
  MircoJ.Friedrich Speaker German Cancer Research Center and HI-STEM GmbHGermany
• Proffered Paper 3: Functional interrogation of rare persistent clones reveals mechanisms of relapse in acute myeloid leukaemia (AML)
  EACR26-0555
  KelsyPrest Speaker Peter MacCallum Cancer CentreAustralia
• Proffered Paper 4: Genetic driver–induced epithelial state continuum unleashes colorectal cancer metastasis
  EACR26-0456
  GabrieleDiamante Speaker Deutsche Krebsforschungszentrum (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)Germany
• Cellular interactions sculpting CNS immunity
  MichaelKilian Speaker Brigham and Women's Hospital and Harvard Medical SchoolUnited States
• Proffered Paper 5: Anti-IFNα autoantibodies improving ICB in melanoma
  EACR26-0667
  AnaïsEBERHARDT Speaker Hospices Civils de Lyon France
• Inhibitor-induced supercharging of protein turnover
  Natalie Scholes Speaker Netherlands Cancer Institute (NKI)Netherlands